Long non-coding RNA RP11-465L10.10 promotes vascular smooth muscle cells phenotype switching and MMP9 expression via the NF-κB pathway
Open Access
- 1 December 2021
- journal article
- research article
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 9 (24) , 1776
Abstract
Background: Thoracic aortic aneurysm/dissection (TAA/D) are complicated vascular disorders with rapid development and high mortality. Vascular smooth muscle cells (VSMCs) phenotype switching plays an important role in the pathological process of TAA/D. Previous studies have indicated a potential correlation between long non-coding RNA (lncRNA) RP11-465L10.10 and matrix metallopeptidase 9 (MMP9) involved in the development of TAA/D. This study aims to investigate the role of lncRNA RP11-465L10.10 in VSMCs phenotype switching and the molecular mechanism in regulating MMP9 expression. Methods: The expression of RP11-465L10.10 in vascular tissues and in VMSCs was detected by RT-qPCR. To investigate the role of RP11-465L10.10 on VSMCs phenotype switching, an RP11-465L10.10-overexpressed lentiviral vector was constructed and transfected into VSMCs. Through EdU staining, migration assay, flow cytometry analysis, the roles of RP11-465L10.10 were estimated. Bioinformatics indicated that RP11-465L10.10 upregulating MMP9 expression via NF-κB signaling, and SN50 (a specific inhibitor of NF-κB pathway) was used to inhibit the NF-κB pathway activation, then the expression of MMP9 was detected in RP11-465L10.10 overexpressed VMSCs. Results: In this study, we found RP11-465L10.10 and MMP9 were highly increased in TAD patient tissues, which was consistent in angiotensin II-induced VSMCs phenotype switching. RP11-465L10.10 overexpression facilitated VSMCs phenotype switching and MMP9 expression. Mechanismly, NF-κB signal pathway was involved in RP11-465L10.10 induced VSMCs phenotype switching and MMP9 expression by transcriptome data analysis and experimental confirm. Conclusion: This study demonstrated that RP11-465L10.10 induces VSMCs phenotype switching and MMP9 expression via the NF-κB signal pathway, suggesting that RP11-465L10.10 might be a potential therapeutic target for TAA/D treatment.Keywords
This publication has 42 references indexed in Scilit:
- The NF-κB signalling pathway in osteoarthritisThe International Journal of Biochemistry & Cell Biology, 2013
- Aortenaneurysma und -dissektionDie Innere Medizin, 2013
- Notch Signaling Change in Pulmonary Vascular Remodeling in Rats with Pulmonary Hypertension and Its Implication for Therapeutic InterventionPLOS ONE, 2012
- Association of smooth muscle cell phenotypes with extracellular matrix disorders in thoracic aortic dissectionJournal of Vascular Surgery, 2012
- Smooth muscle cell phenotypic switching in atherosclerosisCardiovascular Research, 2012
- High-phosphate-induced calcification is related to SM22α promoter methylation in vascular smooth muscle cellsJournal of Bone and Mineral Research, 2010
- The Nuclear Factor NF- B Pathway in InflammationCold Spring Harbor Perspectives in Biology, 2009
- Vascular Extracellular Matrix and Arterial MechanicsPhysiological Reviews, 2009
- Propionyl-L-carnitine Reduces Proliferation and Potentiates Bax-related Apoptosis of Aortic Intimal Smooth Muscle Cells by Modulating Nuclear Factor-κB ActivityJournal of Biological Chemistry, 2007
- Aortic Endothelial and Smooth Muscle Cell Co-Culture: An In Vitro Model of the Arterial WallJournal of Investigative Surgery, 1991